Shanghai-based biotechnology company Innovative Cellular Therapeutics (ICT) has completed a new round of financing from LH Ventures, a venture capital form focusing on disruptive medical industry innovation.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?